A prospective, randomized, double-blind study of the efficacy of Xolair in atopic asthmatics with good lung capacity who remain difficult to treat (EXACT)
Phase of Trial: Phase IV
Latest Information Update: 16 Jun 2017
At a glance
- Drugs Omalizumab (Primary)
- Indications Allergic asthma
- Focus Therapeutic Use
- Acronyms EXACT
- Sponsors Genentech
- 07 Dec 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 27 Apr 2010 Actual patient number (333) added as reported by ClinicalTrials.gov.
- 27 Apr 2010 Planned end date changed from 1 May 2022 to 1 Sep 2010 as reported by ClinicalTrials.gov.